Last reviewed · How we verify
Cardurion Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
2 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Cardiovascular · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Allergan · 1 shared drug class
- Astellas Pharma Inc · 1 shared drug class
- Dr. dr. Lili Legiawati, SpKK(K) · 1 shared drug class
- Eurofarma Laboratorios S.A. · 1 shared drug class
- GlaxoSmithKline · 1 shared drug class
- Kissei Pharmaceutical Co., Ltd. · 1 shared drug class
- Triple Hair Inc · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Cardurion Pharmaceuticals, Inc.:
- Cardurion Pharmaceuticals, Inc. pipeline updates — RSS
- Cardurion Pharmaceuticals, Inc. pipeline updates — Atom
- Cardurion Pharmaceuticals, Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Cardurion Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/cardurion-pharmaceuticals-inc. Accessed 2026-05-17.